title: Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists.
abstract: BACKGROUND
  The diagnosis of B-cell lymphoid malignancy can frequently be substantiated by detecting clonal immunoglobulin heavy chain (IGH) gene rearrangements, which is typically done by polymerase chain reaction (PCR) amplification and/or Southern blot analysis.
  
  
  OBJECTIVE
  To characterize current laboratory practice for the assessment of IGH rearrangements and to identify opportunities for improvement.
  
  
  METHODS
  The data from the Molecular Oncology Proficiency Survey distributed to participating laboratories by the Molecular Pathology Committee of the College of American Pathologists from 1998 through 2003 were analyzed.
  
  
  RESULTS
  Thirty-nine proficiency survey specimens (29 positive and 10 negative for clonal IGH rearrangements) were distributed. For Southern blot analysis, 944 results were reported, with a successful response rate of 95%. For PCR detection, 2349 results were reported, with a successful response rate of 72%. A higher rate of successful responses by PCR was achieved using framework 3 primers in combination with other frameworks (82%) compared with framework 3 primers only (76%) and when fresh/frozen (72%) compared with paraffin-embedded (65%) tissues were analyzed.
  
  
  CONCLUSIONS
  The performance of the participating laboratories was very good, by both Southern blot and PCR analysis. As expected, Southern blot analysis consistently detects a higher proportion of IGH rearrangements than PCR analysis. Further improvement and standardization of the IGH PCR assay is important if it is to replace Southern blot analysis as the standard method. Participation in this survey is a valuable tool for assessing laboratory performance and it directs our attention to areas where we may improve laboratory practice.
authors.affiliation: Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. nikiforovamn@upmc.edu
authors.forename: Marina N
authors.initials: MN
authors.lastname: Nikiforova
authors.forename: Eric D
authors.initials: ED
authors.lastname: Hsi
authors.forename: Rita M
authors.initials: RM
authors.lastname: Braziel
authors.forename: Margaret L
authors.initials: ML
authors.lastname: Gulley
authors.forename: Debra G B
authors.initials: DG
authors.lastname: Leonard
authors.forename: Jan A
authors.initials: JA
authors.lastname: Nowak
authors.forename: Raymond R
authors.initials: RR
authors.lastname: Tubbs
authors.forename: Gail H
authors.initials: GH
authors.lastname: Vance
authors.forename: Vivianna M
authors.initials: VM
authors.lastname: Van Deerlin
mesh_terms: D015139:Blotting, Southern / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D017931:DNA Primers; D003625:Data Collection; D015180:Electrophoresis, Gel, Two-Dimensional; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D008232:Lymphoproliferative Disorders / Q000175:diagnosis; D008495:Medical Oncology / Q000592:standards* / Q000706:statistics & numerical data; D016133:Polymerase Chain Reaction / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D011785:Quality Assurance, Health Care; D012680:Sensitivity and Specificity
chemical_list: D017931:DNA Primers; D007143:Immunoglobulin Heavy Chains